The Journal of Urology
Volume 176, Issue 2 , Pages 569-574 , August 2006

25-Year Prostate Cancer Control and Survival Outcomes: A 40-Year Radical Prostatectomy Single Institution Series

  • Christopher R. Porter

      Affiliations

    • Department of Urology, Virginia Mason Medical Center, Seattle, Washington
    • Corresponding Author InformationCorrespondence: Department of Urologic Oncology, Virginia Mason Medical Center, Section of Urology and Renal Transplantation, Seattle, Washington 98101 (telephone: 206-223-6162; FAX: 206-223-7650).
    • ,
  • Koichi Kodama

      Affiliations

    • Department of Urology, Virginia Mason Medical Center, Seattle, Washington
    • ,
  • Robert P. Gibbons

      Affiliations

    • Department of Urology, Virginia Mason Medical Center, Seattle, Washington
    • ,
  • Roy Correa Jr.

      Affiliations

    • Department of Urology, Virginia Mason Medical Center, Seattle, Washington
    • ,
  • Felix K.-H. Chun

      Affiliations

    • Cancer Prognostics and Health Outcomes Unit, University of Montreal, Montreal, Quebec, Canada
    • ,
  • Paul Perrotte

      Affiliations

    • Cancer Prognostics and Health Outcomes Unit, University of Montreal, Montreal, Quebec, Canada
    • ,
  • Pierre I. Karakiewicz

      Affiliations

    • Cancer Prognostics and Health Outcomes Unit, University of Montreal, Montreal, Quebec, Canada
    • Supported by the Fonds de la Recherche en Santé du Québec, the CHUM Foundation, the Department of Surgery and Les Urologues Associés du CHUM.

Received 2 September 2005

References 

  1. Roehl KA , Han M , Ramos CG , Antenor JA , Catolona WJ . Cancer progression and survival rates following anatomic radical retropubic prostatectomy in 3,478 consecutive patients (long-term results) . J Urol . 2004;172:910
  2. Han M , Partin AW , Pound CR , Epstein JI , Walsh PC . Long-term biochemical disease-free and cancer specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience . Urol Clin North Am . 2001;28:555
  3. Zincke H , Oesterling JE , Blute ML , Bergstralh EJ , Myers RP , Barrett DM . Longterm (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer . J Urol . 1994;152:1850
  4. Hull GW , Rabbani F , Abbas F , Wheeler TM , Kattan MW , Scardino PT . Cancer control with radical prostatectomy alone in 1000 consecutive patients . J Urol . 2002;167:528
  5. Albertson PC , Hanley JA , Fine J . 20-Year outcomes following conservative management of clinically localized prostate cancer . JAMA . 2005;293:2095
  6. Charlson ME , Pompei P , Ales KL , MacKenzie CR . A new method of classifying prognostic comorbidity in longitudinal studies (development and validation) . J Chronic Dis . 1987;40:373
  7. Gibbons RP . Radical perineal prostatectomy . In:  Walsh PC ,  Retik AB ,  Vaughan ED ,  Wein AJ editor. Campbell’s Urology . 7th ed.. Philadelphia: W. B. Saunders Co; 1999; 2589–2588
  8. Catalona WJ . Radical retropubic prostatectomy . In:  Glenn JF editors. Urologic Surgery . 4th ed.. Philadelphia: J. B. Lippincott Co; 1989;p. 616–629
  9. Carter BH , Partin AW . Prostate cancer staging systems . In:  Walsh PC ,  Retik AB ,  Vaughan ED ,  Wein AJ editor. Campbell’s Urology . 7th ed.. Philadelphia: W. B. Saunders Co; 1998;p. 2526
  10. Beahrs OH , Henson DE , Hutter RVP , Kennedy BJ . In: American Joint Committee on Cancer (Manual for Staging of Cancer) . 4th ed.. Philadelphia: J. B. Lippincott Co; 1992;p. 181–186
  11. Gleason DF , Mellinger GT  Veterans Administration Cooperative Urological Research Group . Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging . J Urol . 1974;111:58
  12. Johansson JE , Andren O , Andersson SO , Dickman PW , Holmberg L , Magnuson A , et al.   Natural History of early, localized prostate cancer . JAMA . 2004;291:2713
  13. Ward JF , Blute ML , Slezak J , Bergstralh EJ , Zincke H . The long-term clinical impact of biochemical recurrence of prostate cancer 5 or more years after radical prostatectomy . J Urol . 2003;170:1872
  14. King CR . Patterns of prostate cancer biopsy grading (trends and clinical implications) . Int J Cancer . 2000;90:305
  15. Kondylis FI , Moriarty RP , Bostwick D , Schellhammer PF . Prostate cancer grade assignment (the effect of chronological, interpretive and translational bias) . J Urol . 2003;170:1189
  16. Holmberg L , Bill-Axelson A , Helgesen F , Salo JO , Folmerz P , Haggman M , et al.   A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer . N Engl J Med . 2002;347:781
  17. Eastham JA , Kattan MW , Riedel E , Begg CB , Wheeler TM , Gerigk C , et al.   Variations among individual surgeons in the rate of positive surgical margins in radical prostatectomy specimens . J Urol . 2003;170:2292
  18. Salomon L , Levrel O , de la Taille A , Anastasiadis AG , Saint F , Zaki S , et al.   Radical prostatectomy by the retropubic, perineal and laparoscopic approach (12 years of experience in one center) . Eur Urol . 2002;42:104
  19. Stamey TA , Caldwell M , McNeal JE , Nolley R , Hemenez M , Downs J . The prostate specific antigen era in the United States is over for prostate cancer (what happened in the last 20 years?) . J Urol . 2004;172:1297

PII: S0022-5347(06)00774-9

doi: 10.1016/j.juro.2006.03.094

The Journal of Urology
Volume 176, Issue 2 , Pages 569-574 , August 2006

Article Tools

* Image Usage & Resolution